Treosulfan Based Conditioning Acute Myeloid Leukaemia (AML)

Clinical trial NCT01063660 · COMPLETED

Trial details

NCT number: NCT01063660
Sponsor: medac GmbH
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukaemia

Start date: 2004-03-01
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.